Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioImagene and Scimagix Merge to Provide Comprehensive Image Analysis and Informatics Solutions.


SAN JOSE San Jose, city, United States
San Jose (sănəzā`, săn hōzā`), city (1990 pop. 782,248), seat of Santa Clara co., W central Calif.; founded 1777, inc. 1850.
, Calif. -- BioImagene and Scimagix are pleased to announce their merger. The combination of BioImagene's core competency A core competency is something that a firm can do well and that meets the following three conditions specified by Hamel and Prahalad (1990):
  1. It provides customer benefits
  2. It is hard for competitors to imitate
  3. It can be leveraged widely to many products and markets.
 in image analysis with Scimagix' image management and data mining technology address major pain-points in the discovery and diagnostics markets. Together, they will provide complete, integrated solutions for gels, cells and tissues, from initial analysis to data mining and post-hoc analysis Post-hoc analysis, in the context of design and analysis of experiments, refers to looking in the data—after the experiment has concluded—for patterns that were not specified a priori. . This comprehensive, web-enabled suite of products is a major step toward the companies' joint goal of enabling digital discovery and diagnostics.

"Scimagix provides a very good strategic fit with BioImagene. Together we have a critical mass of technology, products, customers and partners that positions us as a leading player in the marketplace," said Mohan Uttarwar, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of BioImagene, and of the combined company going forward.

"This is a major step toward the fulfillment of image informatics' promise of advancing science, technology and healthcare. BioImagene and Scimagix together will extend and amplify these benefits. The combined offerings will be very valuable to our customers. They will facilitate a seamless workflow resulting in higher through-put and higher productivity, translating into improved discovery and diagnostic processes and outcomes," said Robert Dunkle, President of Scimagix.

And customers of both BioImagene and Scimagix agree. "I'm very encouraged about the merging of these technology platforms," said Bruce Keyt, VP of Preclinical preclinical /pre·clin·i·cal/ (-klin´i-k'l) before a disease becomes clinically recognizable.

pre·clin·i·cal
adj.
1.
 Development at Abgenix, and a customer of both companies. "It relieves me of concerns regarding reinventing the wheel Reinventing the wheel is a phrase that means a generally accepted technique or solution is ignored in favor of a locally invented solution. To "reinvent the wheel" is to duplicate a basic method that has long since been accepted and even taken for granted. . We won't have to worry about integration challenges when we use Scimagix' storage and data mining tools for the data we get from BioImagene's quantitation and analysis. This will broaden our information transfer technology. We've worked a great deal with both Scimagix and BioImagene. These technologies working together will provide very powerful tools for evaluating therapeutic antibodies at Abgenix."

The combined company will provide all existing customers with ongoing support, maintenance and further development of both companies' product lines.

About BioImagene

BioImagene provides sophisticated bio-image analysis products built on iHarness, its patent-pending technology platform. BioImagene's products allow physicians and researchers to analyze and interpret images with far greater speed and consistency. The data management systems of BioImagene's technology facilitate communication and collaboration, improving the standard of patient care and increasing the speed of discovery. Its scalable digital image analysis solutions have been embraced by clinicians, industry and researchers alike.

BioImagene is headquartered in San Jose, California San Jose (IPA: /ˌsænhoʊˈzeɪ/) is the third-largest city in California, and the tenth-largest in the United States. It is the county seat of Santa Clara County. . For more information on BioImagene, visit the company's web site at www.bioimagene.com.

About Scimagix

Scimagix(R) Inc., based in San Mateo San Mateo (săn mətā`ō), city (1990 pop. 85,486), San Mateo co., W Calif., on San Francisco Bay; inc. 1894. It is a commercial and retail center with some high-technology manufacturing. San Mateo, Spanish for St. , Calif., is the leading provider of image informatics Same as information technology and information systems. The term is more widely used in Europe.  solutions for pharmaceutical research and development (R&D). Its flagship SIMS(R) (Scientific Image Management System) platform, an Oracle(R)/Web-based database management system, utilizes open architecture to deliver a comprehensive and searchable image database. Image informatics technology integrates valuable image and non-image data into SIMS, allowing scientists to search, mine and analyze all results. ProteinMine(TM), running on top of SIMS, supports high throughput analysis and mining of image data with proprietary visual content search technology, dramatically increasing the accuracy and productivity of R&D processes. Scimagix serves most of the top 15 pharmaceutical companies including Pfizer Global R&D, Hoffmann La Roche La Roche may refer to:
  • Hoffmann-La Roche
  • La Roche College
Places
  • Belgium
  • La Roche-en-Ardenne, a small town in the Ardennes
  • Switzerland
 and Eli Lilly Eli Lilly can refer to:
  • Eli Lilly and Company, a global pharmaceutical company
  • Colonel Eli Lilly (1839-1898), founder of Eli Lilly and Company
  • Eli Lilly (industrialist) (1885-1977), former president of Eli Lilly and Company
 & Co. For more information about Scimagix, please visit www.scimagix.com/.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 10, 2004
Words:539
Previous Article:Reed Exhibitions, Sister Company of Elsevier Health Sciences, Launched Reed Medical Education to Focus on Health and Medical Events.
Next Article:To Remain ``Merry'' This Holiday Season, AAA Urges Motorists Not to Become Another Breakdown Statistic.



Related Articles
Scimagix To Improve Cellular Screening and Data Mining With Image Informatics; Hyseq Pharmaceuticals to Serve as Test Site for SIMS Software.
Scimagix Provides Enhanced Functionality and Increased Automation for Scientific Image Analysis; ProteinMine 1.5 Enables Fast, Accurate Comparison of...
Scimagix improves Scientific Image analysis.
Ohio State University College of Medicine Signs a Collaboration Agreement on Digital Pathology with BioImagene.
BioImagene Meets with FDA Officials to Discuss Pre-IDE Submission of the Diagnostic Product Version of Its PATHIAM(TM) Software.
Novel technologies for in vivo imaging.
BioImagene Inc. to Present at Medtech Insight and Windhover Information's ``Investment In Innovation (In3) WEST'' Conference, February 23-24, 2006,...
MERGE EMED YIELDS POSITIVE FINANCIAL FEEDBACK.
Spotfire and BioImagene Integration to Speed-up Analytical Research in the Life Science Industry.
BioImagene Unveils the Robust 3i Platform for Image Informatics Solutions.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles